Kali Coleman

Kali Coleman is a senior editor who utilizes her love for service journalism by providing readers with the news they need every day. Her writing has been published by Best Life, Eat This, Not That, Yahoo, MSN, Newsbreak, Irish Daily Star, The Lancaster News, and Carolina Gateway. She has been covering different areas of breaking news for over five years. During the height of the COVID-19 pandemic, she kept readers informed on the latest health research, insight from Dr. Fauci, and retail closures. More recently, she has become an expert on all things involving the U.S. Postal Service (USPS) and Louis DeJoy. Kali began her career as a recipient of the South Carolina Press Association's prestigious 2017 internship award, where she was placed as a paid intern for The Lancaster News' special weekly publication, Carolina Gateway. She quickly received multiple front-page bylines for both papers, predominantly covering the race for South Carolina's 5th Congressional District Special Election in 2017. At the beginning of 2019, Kali moved to New York to work as an editorial intern at Best Life. She was offered a permanent position on the team as an assistant editor just a few short months into her internship. Since then, Kali has continued to work her way up to her current role as senior editor.

Biography:  https://bestlifeonline.com/author/kali-coleman/

97%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This author is known for its high journalistic standards. The author strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. The author has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

95%

Examples:

  • There's no denying the impact that Ozempic and other similar medications have had over the past year. But the three new studies have concluded that all GLP-1 drugs carry a rare but consistent risk of gastroparesis.

Conflicts of Interest

100%

Examples:

No current examples available.

Contradictions

100%

Examples:

No current examples available.

Deceptions

100%

Examples:

No current examples available.

Recent Articles

GLP-1 Agonists and Gastroparesis: Uncovering the Connection and Its Implications

GLP-1 Agonists and Gastroparesis: Uncovering the Connection and Its Implications

Broke On: Monday, 20 May 2024 Weight loss drugs, such as GLP-1 agonists like Ozempic and Wegovy, have been linked to an increased risk of gastroparesis. Studies suggest that 10 out of every 10,000 people taking these medications for weight loss are diagnosed with gastroparesis at least six months later compared to 4 out of every 10,000 people not taking the medication. Over fifty lawsuits have been filed against drug manufacturers due to potential side effects and lack of clear warnings about this risk.